Wißfeld, Jannis
Mathews, Mona
Mossad, Omar
Picardi, Paola
Cinti, Alessandro
Redaelli, Loredana
Pradier, Laurent
Brüstle, Oliver
Neumann, Harald
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO), Grant agreement No. 115976 (PHAGO))
Deutsche Forschungsgemeinschaft (FOR2953 (NE507/16-1 Nr. 432190414))
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 10 November 2020
Accepted: 7 June 2021
First Online: 29 June 2021
Competing interests
: MM, PP, AC, LR, LP and OB are employed by a company with activities related to the topic of this manuscript. MM and OB are named inventors of a submitted patent related to upscaled production of iPSC-derived microglia and macrophages (EP20162230) that is assigned to the LIFE & BRAIN GmbH. OB and HN are named inventors on a patent related to generation of microglial precursors from pluripotent stem cells (patent family to WO2010125107A1<sup>34</sup>) that is assigned to the LIFE & BRAIN GmbH and the University of Bonn. JW and OM declare no potential conflict of interest.